Literature DB >> 16123314

Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism.

Manuel Mayr1, Yuen-Li Chung, Ursula Mayr, Xiaoke Yin, Lucy Ly, Helen Troy, Salim Fredericks, Yanhua Hu, John R Griffiths, Qingbo Xu.   

Abstract

OBJECTIVE: Proteomics and metabolomics are emerging technologies to study molecular mechanisms of diseases. We applied these techniques to identify protein and metabolite changes in vessels of apolipoprotein E(-/-) mice on normal chow diet. METHODS AND
RESULTS: Using 2-dimensional gel electrophoresis and mass spectrometry, we identified 79 protein species that were altered during various stages of atherogenesis. Immunoglobulin deposition, redox imbalance, and impaired energy metabolism preceded lesion formation in apolipoprotein E(-/-) mice. Oxidative stress in the vasculature was reflected by the oxidation status of 1-Cys peroxiredoxin and correlated to the extent of lesion formation in 12-month-old apolipoprotein E(-/-) mice. Nuclear magnetic resonance spectroscopy revealed a decline in alanine and a depletion of the adenosine nucleotide pool in vessels of 10-week-old apolipoprotein E(-/-) mice. Attenuation of lesion formation was associated with alterations of NADPH generating malic enzyme, which provides reducing equivalents for lipid synthesis and glutathione recycling, and successful replenishment of the vascular energy pool.
CONCLUSIONS: Our study provides the most comprehensive dataset of protein and metabolite changes during atherogenesis published so far and highlights potential associations of immune-inflammatory responses, oxidative stress, and energy metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123314     DOI: 10.1161/01.ATV.0000183928.25844.f6

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  54 in total

Review 1.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 2.  Proteomic and metabolomic profiles in atherothrombotic vascular disease.

Authors:  Roxana Martinez-Pinna; Coral Barbas; Luis Miguel Blanco-Colio; Jose Tunon; Priscila Ramos-Mozo; Juan Antonio Lopez; Olivier Meilhac; Jean-Baptiste Michel; Jesus Egido; José Luis Martin-Ventura
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

3.  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Authors:  R Karasawa; M S Kurokawa; K Yudoh; K Masuko; S Ozaki; T Kato
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 4.  Metabonomics techniques and applications to pharmaceutical research & development.

Authors:  John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 5.  Proteomics of acute coronary syndromes.

Authors:  Athanasios Didangelos; David Simper; Claudia Monaco; Manuel Mayr
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 6.  Molecular imaging will replace myocardial perfusion imaging.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

7.  NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.

Authors:  Gregory C Leo; Andrew L Darrow
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

8.  Proteomics characterization of extracellular space components in the human aorta.

Authors:  Athanasios Didangelos; Xiaoke Yin; Kaushik Mandal; Mark Baumert; Marjan Jahangiri; Manuel Mayr
Journal:  Mol Cell Proteomics       Date:  2010-06-15       Impact factor: 5.911

9.  Metabolomic analysis of human disease and its application to the eye.

Authors:  Stephen P Young; Graham R Wallace
Journal:  J Ocul Biol Dis Infor       Date:  2009-11-13

10.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.